Massive survey aims to map haemophilia in Asia-Pacific
NCT ID NCT07163260
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects information from doctors and patient groups across Asia and the Pacific to better understand how haemophilia affects people in the region. No treatments or medications are given; instead, researchers will analyze data on how many people have the condition, how often new cases occur, and what care is currently available. The goal is to improve future care and support for people with haemophilia.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Novo Nordisk Investigational Site
Bangalore, Karnataka, 560 066, India
-
Novo Nordisk Investigational Site
Kuala Lumpur, 50470, Malaysia
-
Novo Nordisk Investigational Site
Seoul, South Korea
-
Novo Nordisk Investigational Site
Bangkok, 10500, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Once-a-Week shot could transform hemophilia Care—Even for those with inhibitors
- Gene Editing's lasting impact: a 10-Year safety watch
- Can a single gene shot free hemophilia b patients from regular infusions?
- Can a video call replace the clinic for hemophilia pain relief?
- Newborn screening study aims to catch rare diseases at birth
- Monthly shot could free kids with hemophilia from frequent infusions